Vipul
NSE
₹ 0.00
0.00 (0.00)%
Small-cap
With a market cap of ₹18.90L Cr.
EX-Date | Purpose |
---|---|
30 06 2021 | Dividend & Audited Results |
19 07 2021 | We would like to inform that the said Board Meeting stands postponed for now and new date shall be informed in due course, the meeting shall be convened through audio visual means of communication to, inter alia, to consider and approve the Audited Financial Results for the 4th Quarter and Financial Year ended March 31, 2021 (Standalone and Consolidated) and to consider and recommend Dividend for the Financial Year ended March 31, 2021, if any, in view of the initiation of Corporate Insolvency Resolution Process and appointment of Mr. Ravi Sethia, Insolvency Professional (IBBI Registration No. IBBI/IPA-001/IP-P01305/2018-19/12052) as the Interim Resolution Professional (IRP) of the Company by the order of Hon ble NCLT dated July 12, 2021. (copy enclosed) The IRP needs some time to review the accounts of the Company, hence the postponement. |
02 08 2021 | Dividend(Cancelled) (Cancelled) & Audited Results(Cancelled) |
09 08 2021 | Dividend |
14 08 2021 | Quarterly Results |
21 08 2021 | Quarterly Results (Revised) |
12 11 2021 | Quarterly Results |
14 02 2022 | Quarterly Results |
25 05 2022 | Dividend & Audited Results |
30 05 2022 | Dividend (Revised) & Audited Results |
09 08 2022 | Quarterly Results |
11 08 2022 | Quarterly Results (Revised) |
11 11 2022 | Quarterly Results |
14 02 2023 | Quarterly Results |
30 05 2023 | Dividend & Audited Results |
06 06 2023 | Dividend (Revised) & Audited Results |
11 08 2023 | Quarterly Results |
10 11 2023 | Quarterly Results |
13 02 2024 | Quarterly Results |
05 03 2024 | Preferential Issue of shares & Issue Of Warrants |
07 11 2024 | Quarterly Results |
10 12 2024 | Inter alia, to consider and approve, inter alia, proposal for raising funds through issuance of equity shares or any other equity linked instruments or securities including convertible preference shares, and/or bonds including foreign currency convertible bonds/debentures/non-convertible debt instruments along with warrants/convertible debentures/ securities and/or any other equity based instruments, inter alia, a private placement or through one or more qualified institutional placement (QIP) and/or further public issue of equity and/or rights issue and/or preferential allotment and/or through any other permissible mode in accordance with the relevant provisions of applicable law, subject to approval from the shareholders of the Company and the receipt of statutory /regulatory and other approvals. |
05 02 2025 | Quarterly Results |
No News data available